MiR-503 regulates osteoclastogenesis via targeting RANK

Journal of Bone and Mineral Research

Volumn 29, Issue 2, 2014, Pages 338-347

  Chen, Chao ^a   Cheng, Peng ^a   Xie, Hui ^a   Zhou, Hou De ^a   Wu, Xian Ping ^a   Liao, Er Yuan ^a   Luo, Xiang Hang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

microRNA; OSTEOCLASTOGENESIS; OSTEOPOROSIS; PBMCs; RANK

Indexed keywords

ANTAGOMIR; CD14 ANTIGEN; MICRORNA; MICRORNA 503; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ARTICLE; BONE MASS; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MIDDLE AGED; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OVARIECTOMY; PERIPHERAL BLOOD MONONUCLEAR CELL; POSTMENOPAUSE OSTEOPOROSIS; PROTEIN TARGETING;

MICRORNA; OSTEOCLASTOGENESIS; OSTEOPOROSIS; PBMCS; RANK;

ANIMALS; ANTIGENS, CD14; CELL DIFFERENTIATION; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MICE; MICRORNAS; MIDDLE AGED; OSTEOCLASTS; OSTEOPOROSIS, POSTMENOPAUSAL; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; STEM CELLS;

EID: 84892719952     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2032     Document Type: Article

References (39)

1. Gruber HE, Ivey JL, Thompson ER, Chesnut CH 3rd, Baylink DJ,. Osteoblast and osteoclast cell number and cell activity in postmenopausal osteoporosis. Miner Electrolyte Metab. 1986; 12 (4): 246-54.
2. Segovia-Silvestre T, Neutzsky-Wulff AV, Sorensen MG, Christiansen C, Bollerslev J, Karsdal MA, Henriksen K,. Advances in osteoclast biology resulting from the study of osteopetrotic mutations. Hum Genet. 2009; 124 (6): 561-77.
3. Wang C, Zhang Z, Zhang H, He JW, Gu JM, Hu WW, Hu YQ, Li M, Liu YJ, Fu WZ, Yue H, Ke YH, Zhang ZL,. Susceptibility genes for osteoporotic fracture in postmenopausal Chinese women. J Bone Miner Res. 2012; 27 (12): 2582-91.
4. Liu JM, Zhang MJ, Zhao L, Cui B, Li ZB, Zhao HY, Sun LH, Tao B, Li M, Ning G,. Analysis of recently identified osteoporosis susceptibility genes in Han Chinese women. J Clin Endocrinol Metab. 2010; 95 (9): E112-20.
5. Xia WB, He SL, Xu L, Liu AM, Jiang Y, Li M, Wang O, Xing XP, Sun Y, Cummings SR,. Rapidly increasing rates of hip fracture in Beijing, China. J Bone Miner Res. 2012; 27 (1): 125-9.
6. Sorensen MG, Henriksen K, Schaller S, Henriksen DB, Nielsen FC, Dziegiel MH, Karsdal MA,. Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood. J Bone Miner Metab. 2007; 25 (1): 36-45.
7. Hemingway F, Cheng X, Knowles HJ, Estrada FM, Gordon S, Athanasou NA,. In vitro generation of mature human osteoclasts. Calcif Tissue Int. 2011; 89 (5): 389-95.
8. Shalhoub V, Elliott G, Chiu L, Manoukian R, Kelley M, Hawkins N, Davy E, Shimamoto G, Beck J, Kaufman SA, Van G, Scully S, Qi M, Grisanti M, Dunstan C, Boyle WJ, Lacey DL,. Characterization of osteoclast precursors in human blood. Br J Haematol. 2000; 111 (2): 501-12.
9. Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Elliott R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, Boyle WJ,. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA. 1999; 96 (7): 3540-5.
10. Carthew RW, Sontheimer EJ,. Origins and mechanisms of miRNAs and siRNAs. Cell. 2009; 136 (4): 642-55.
11. Schramke V, Allshire R,. Hairpin RNAs and retrotransposon LTRs effect RNAi and chromatin-based gene silencing. Science. 2003; 301 (5636): 1069-74.
12. Noma K, Sugiyama T, Cam H, Verdel A, Zofall M, Jia S, Moazed D, Grewal SI,. RITS acts in cis to promote RNA interference-mediated transcriptional and post-transcriptional silencing. Nat Genet. 2004; 36 (11): 1174-80.
13. Sugatani T, Vacher J, Hruska KA,. A microRNA expression signature of osteoclastogenesis. Blood. 2011; 117 (13): 3648-57.
14. Sugatani T, Hruska KA,. MicroRNA-223 is a key factor in osteoclast differentiation. J Cell Biochem. 2007; 101 (4): 996-9.
15. Mann M, Barad O, Agami R, Geiger B, Hornstein E,. miRNA-based mechanism for the commitment of multipotent progenitors to a single cellular fate. Proc Natl Acad Sci USA. 2010; 107 (36): 15804-9.
16. Sugatani T, Hruska KA,. Impaired micro-RNA pathways diminish osteoclast differentiation and function. J Biol Chem. 2009; 284 (7): 4667-78.
17. Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N,. The diagnosis of osteoporosis. J Bone Miner Res. 1994; 9 (8): 1137-41.
18. Wu XP, Liao EY, Zhang H, Shan PF, Cao XZ, Liu SP,. Establishment of BMD reference plots and determination of peak BMD at multiple skeletal regions in mainland Chinese women and the diagnosis of osteoporosis. Osteoporos Int. 2004; 15 (1): 71-9.
19. Liao EY, Wu XP, Luo XH, Zhang H, Dai RC, Huang G, Wang WB,. Establishment and evaluation of bone mineral density reference databases appropriate for diagnosis and evaluation of osteoporosis in Chinese women. J Bone Miner Metab. 2003; 21 (3): 184-92.
20. Halleen JM, Alatalo SL, Suominen H, Cheng S, Janckila AJ, Vaananen HK,. Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption. J Bone Miner Res. 2000; 15 (7): 1337-45.
21. Swaminathan R,. Biochemical markers of bone turnover. Clin Chim Acta. 2001; 313 (1-2): 95-105.
22. Bartel DP,. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116 (2): 281-97.
23. Hagen JW, Lai EC,. MicroRNA control of cell-cell signaling during development and disease. Cell Cycle. 2008; 7 (15): 2327-32.
24. Zhao Q, Wang X, Liu Y, He A, Jia R,. NFATc1: functions in osteoclasts. Int J Biochem Cell Biol. 2010; 42 (5): 576-9.
25. Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I,. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature. 2008; 455 (7216): 1124-8.
26. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, Lim B, Rigoutsos I,. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell. 2006; 126 (6): 1203-17.
27. Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Yano K, Morinaga T, Higashio K,. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem Biophys Res Commun. 1998; 253 (2): 395-400.
28. Cheng P, Chen C, He HB, Hu R, Zhou HD, Xie H, Zhu W, Dai RC, Wu XP, Liao EY, Luo XH,. MiR-148a regulates osteoclastogenesis via targeting MAFB. J Bone Miner Res. 2013; 28 (5): 1180-90.
29. Nakasa T, Shibuya H, Nagata Y, Niimoto T, Ochi M,. The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis. Arthritis Rheum. 2011; 63 (6): 1582-90.
30. Zhao JJ, Yang J, Lin J, Yao N, Zhu Y, Zheng J, Xu J, Cheng JQ, Lin JY, Ma X,. Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst. 2009; 25 (1): 13-20.
31. Corbetta S, Vaira V, Guarnieri V, Scillitani A, Eller-Vainicher C, Ferrero S, Vicentini L, Chiodini I, Bisceglia M, Beck-Peccoz P, Bosari S, Spada A,. Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue. Endocr Relat Cancer. 2010; 17 (1): 135-46.
32. Tombol Z, Szabo PM, Molnar V, Wiener Z, Tolgyesi G, Horanyi J, Riesz P, Reismann P, Patocs A, Liko I, Gaillard RC, Falus A, Racz K, Igaz P,. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis. Endocr Relat Cancer. 2009; 16 (3): 895-06.
33. Forrest AR, Kanamori-Katayama M, Tomaru Y, Lassmann T, Ninomiya N, Takahashi Y, de Hoon MJ, Kubosaki A, Kaiho A, Suzuki M, Yasuda J, Kawai J, Hayashizaki Y, Hume DA, Suzuki H,. Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. Leukemia. 2010; 24 (2): 460-6.
34. Sarkar S, Dey BK, Dutta A,. MiR-322/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A. Mol Biol Cell. 2010; 21 (13): 2138-49.
35. Caporali A, Meloni M, Vollenkle C, Bonci D, Sala-Newby GB, Addis R, Spinetti G, Losa S, Masson R, Baker AH, Agami R, le Sage C, Condorelli G, Madeddu P, Martelli F, Emanueli C,. Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia. Circulation. 2011; 123 (3): 282-91.
36. Wang Y, Grainger DW,. siRNA knock-down of RANK signaling to control osteoclast-mediated bone resorption. Pharm Res. 2010; 27 (7): 1273-84.
37. Kapur RP, Yao Z, Iida MH, Clarke CM, Doggett B, Xing L, Boyce BF,. Malignant autosomal recessive osteopetrosis caused by spontaneous mutation of murine Rank. J Bone Miner Res. 2004; 19 (10): 1689-97.
38. Pangrazio A, Cassani B, Guerrini MM, Crockett JC, Marrella V, Zammataro L, Strina D, Schulz A, Schlack C, Kornak U, Mellis DJ, Duthie A, Helfrich MH, Durandy A, Moshous D, Vellodi A, Chiesa R, Veys P, Lo Iacono N, Vezzoni P, Fischer A, Villa A, Sobacchi C,. RANK-dependent autosomal recessive osteopetrosis: characterization of five new cases with novel mutations. J Bone Miner Res. 2012; 27 (2): 342-51.
39. Wang Y, Li L, Moore BT, Peng XH, Fang X, Lappe JM, Recker RR, Xiao P,. MiR-133a in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis. PLoS One. 2012; 7 (4): e34641.